Keyword: National Institutes of Health
Merck & Co. struck a deal with Brazil's Butantan Institute to push ahead with their respective dengue development programs.
An initial analysis showed that J&J's four-strain HIV vaccine elicited a broader immune response than an older trivalent version.
Johnson & Johnson's "mosaic" HIV vaccine regimen elicited immune responses one year after the final shot.
BiondVax enrolled its first patient in a phase 2 U.S. study of its universal flu vaccine, which aims to fight off all strains of the virus at the same time.
Nonprofit PATH secured a major commitment from the Gates Foundation for its new vaccine group.
HHS Secretary Tom Price offered some optimism about a vaccine for addiction, but experts say such it's far from reality.
Meissa Vaccines, a JLABS resident startup, has financial backing from the NIH and a VC firm to help advance its RSV vaccine candidate.
Scientists at the University of Maryland, hoping to fill the hepatitis vaccine void, have secured funding from the NIH to work on a new candidate.
A U.S. Army official dismissed critics targeting Sanofi's pending license for a government-funded Zika vaccine candidate.
Themis is the most recent company to usher a Zika vaccine to the clinic.